ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Senators Urge study section On Clinical Cancer Research

February 4, 1994

In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review

November 3, 1978

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

NCI Should Toughen Deadlines, Quality, in RAID program, Advisory Committee Says.

October 6, 2006

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004